Login / Signup

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Nikola MitrevN Vande CasteeleCynthia H-T SeowJ M AndrewsS J ConnorG T MooreM BarclayJ BegunR BryantWebber Pak Wo ChanC CorteS GhalyD A LembergV KariyawasamP LewindonJ MartinR MountifieldG Radford-SmithP SlobodianMiles Patrick SparrowC ToongD van LangenbergMark G WardRupert W L Leongnull null
Published in: Alimentary pharmacology & therapeutics (2017)
Consensus statements support the role of TDM in optimising anti-TNF agents to treat IBD, especially in situations of treatment failure.
Keyphrases
  • rheumatoid arthritis
  • clinical practice
  • stem cells
  • cell therapy
  • ulcerative colitis
  • smoking cessation